Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14030 | 733 | 47.3 | 95% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SHIP2 | Author keyword | 52 | 76% | 5% | 37 |
2 | INOSITOL 5 PHOSPHATASE | Author keyword | 17 | 79% | 2% | 11 |
3 | SHIP1 | Author keyword | 16 | 64% | 2% | 16 |
4 | SHIP 1 | Author keyword | 10 | 58% | 2% | 11 |
5 | DOK | Author keyword | 9 | 59% | 1% | 10 |
6 | INOSITOL PHOSPHATASE | Author keyword | 8 | 62% | 1% | 8 |
7 | DOK1 | Author keyword | 7 | 57% | 1% | 8 |
8 | PHOSPHATIDYLINOSITOL METABOLISM | Author keyword | 5 | 34% | 2% | 11 |
9 | DOK2 | Author keyword | 4 | 67% | 1% | 4 |
10 | IMMUNOL CELLULAIRE CLIN | Address | 4 | 28% | 2% | 13 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SHIP2 | 52 | 76% | 5% | 37 | Search SHIP2 | Search SHIP2 |
2 | INOSITOL 5 PHOSPHATASE | 17 | 79% | 2% | 11 | Search INOSITOL+5+PHOSPHATASE | Search INOSITOL+5+PHOSPHATASE |
3 | SHIP1 | 16 | 64% | 2% | 16 | Search SHIP1 | Search SHIP1 |
4 | SHIP 1 | 10 | 58% | 2% | 11 | Search SHIP+1 | Search SHIP+1 |
5 | DOK | 9 | 59% | 1% | 10 | Search DOK | Search DOK |
6 | INOSITOL PHOSPHATASE | 8 | 62% | 1% | 8 | Search INOSITOL+PHOSPHATASE | Search INOSITOL+PHOSPHATASE |
7 | DOK1 | 7 | 57% | 1% | 8 | Search DOK1 | Search DOK1 |
8 | PHOSPHATIDYLINOSITOL METABOLISM | 5 | 34% | 2% | 11 | Search PHOSPHATIDYLINOSITOL+METABOLISM | Search PHOSPHATIDYLINOSITOL+METABOLISM |
9 | DOK2 | 4 | 67% | 1% | 4 | Search DOK2 | Search DOK2 |
10 | DOK5 | 4 | 75% | 0% | 3 | Search DOK5 | Search DOK5 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | POLYPHOSPHATE 5 PHOSPHATASE | 76 | 67% | 9% | 68 |
2 | PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE | 68 | 80% | 6% | 43 |
3 | P62DOK | 65 | 84% | 5% | 36 |
4 | POLYPHOSPHATE 5 PHOSPHATASE SHIP | 62 | 92% | 3% | 24 |
5 | PHOSPHATASE SHIP | 57 | 70% | 7% | 48 |
6 | INOSITOL PHOSPHATASE SHIP | 40 | 48% | 8% | 61 |
7 | 5 PHOSPHATASE SHIP | 32 | 78% | 3% | 21 |
8 | PHOSPHATASE SHIP2 | 27 | 83% | 2% | 15 |
9 | FC GAMMA RIIB | 23 | 23% | 12% | 89 |
10 | INOSITOL POLYPHOSPHATE 5 PHOSPHATASE | 21 | 33% | 7% | 52 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease | 2009 | 107 | 283 | 36% |
Discovery and Development of Small Molecule SHIP Phosphatase Modulators | 2014 | 3 | 136 | 62% |
Structure, function, and biology of SHIP proteins | 2000 | 190 | 103 | 53% |
The roles of Dok family adapters in immunoreceptor signaling | 2009 | 52 | 120 | 51% |
Role of SHIP in cancer | 2011 | 18 | 110 | 57% |
Phosphoinositide signalling in cancer: beyond PI3K and PTEN | 2010 | 148 | 119 | 18% |
Enzymatic and non-enzymatic activities of SHIP-1 in signal transduction and cancer | 2011 | 10 | 95 | 77% |
The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases | 2003 | 55 | 67 | 73% |
The role of SHIP in macrophages | 2007 | 26 | 118 | 58% |
The role of phosphatases in inositol signaling reactions | 1999 | 139 | 55 | 45% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IMMUNOL CELLULAIRE CLIN | 4 | 28% | 1.8% | 13 |
2 | H LEE MOFFITT COMPREHENS CANC | 4 | 50% | 0.8% | 6 |
3 | RECH INTERDISCIPLINAIRE IRIBHM | 3 | 45% | 0.7% | 5 |
4 | INFLAMMATORY CELL BIOL | 2 | 33% | 0.5% | 4 |
5 | UNITE ALLERGOL MOL CELLULAIRE | 1 | 19% | 1.0% | 7 |
6 | BIOCHEM MOL IMMUNOL | 1 | 19% | 0.7% | 5 |
7 | BIOCHEM MOL BIOL 1 CELLULAR SIGNAL TRANSDU | 1 | 50% | 0.1% | 1 |
8 | CANC IMMUNOL MARSEILLE | 1 | 50% | 0.1% | 1 |
9 | CLIN PHARMACOL CAMBRIDGE MED | 1 | 50% | 0.1% | 1 |
10 | E9911 | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000251886 | LOWE SYNDROME//OCULOCEREBRORENAL SYNDROME//OCRL1 |
2 | 0.0000141057 | PIKFYVE//PTDINS5P//GOLPH3 |
3 | 0.0000114341 | BIOL CHEMBUNKYO KU//DEMETHOXYVIRIDIN//2 4 MORPHOLINYL 8 PHENYLCHROMONE |
4 | 0.0000102124 | SLP 76//LINKER FOR ACTIVATION OF T CELLS//SECT LYMPHOCYTE SIGNALING |
5 | 0.0000099345 | P66SHC//SHC//SHC FAMILY |
6 | 0.0000091069 | LAIR 1//CD300A//FCRL |
7 | 0.0000084694 | P110 ALPHA//PIK3CA//PI3K ALPHA |
8 | 0.0000082761 | SHP 2//SHP 1//GAB1 |
9 | 0.0000080747 | FC GAMMA RECEPTORS//FC RECEPTOR//FC GAMMA RIIA |
10 | 0.0000070804 | SIGLEC//SIGLECS//SIGLEC 8 |